Spontaneous melanocytosis in transgenic mice

Journal of Investigative Dermatology

Volumn 106, Issue 5, 1996, Pages 1145-1151

  Chen, Suzie ^a   Zhu, Hua ^a   Wetzel, William J ^b   Philbert, Martin A ^c  

^a RUTGERS UNIVERSITY   (United States)

^b Department of Pathology   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Differentiation; Insertion mutagenesis

Indexed keywords

MELANIN; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MELANOCYTOSIS; MELANOMA; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0029968919     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12340194     Document Type: Article

References (32)

1. Berkelhammer J, Oxenhandler R: Evaluation of premalignant and malignant lesions during the induction of mouse melanomas. Cancer Res 47:1251-1254, 1987
2. Blanck G, Chen S, Pollack R: Reversion to anchorage dependent growth control deletes specific SV40 DNA sequences despite continued expression of SV40 early region. Virology 126:413-428, 1983
3. Bradl M, Klein-Szanto A, Porter S, Mintz B: Malignant melanoma in transgenic mice. Proc Natl Acad Sci USA 88:164-168, 1991
4. Brucker EB, Suter L, Bruggen J, Ruiter DJ, Macher E, Sorg C: Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer 36:29-35, 1985
5. Cajal S, Suster S, Halaban R, Filvaroff E, Dotto G: Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu, and E1a oncogenes. Am J Pathol 138:349-358, 1991
6. Chen S, Teicher L, Kazim D, Pollack RE, Wise LS: DNA for human fat and undifferentiated preadipocyte mouse cells commits mouse fibroblasts to adipocyte differentiation. Science 244:582-585, 1989
7. Clark WM Jr., Watson MC, Watson BEM: Two kinds of clear cells in the human epidermis: with a report of a modified DOPA reaction for electron microscopy. Am J Pathol 39:333-344, 1961
8. Cochran AJ, Wen D-R: S-100 protein as a marker for melanocytic and other tumours. Pathology 17:340-345, 1985
9. Colon-Teicher L, Wise L, Martino J, Baskin L, Sakoulas G, Pollack R, Chen, S: Genomic sequences capable of committing mouse and rat fibroblasts to adipogenesis. Nucleic Acid Res 21:2223-2228, 1993
10. Duray PH, Palazzo J, Gown AM, Ohuchi N: Melanoma cell heterogeneity: a study to two monoclonal antibodies compared with S-100 protein in paraffin sections. Cancer 61:2460-2469, 1987
11. Foley GL, Valentine BA, Kincaid AL: Congenital and acquired melanocytomas (benign melanomas) eighteen young horses. Vet Pathol 28:363-369, 1991
12. Frangioni F, Borgioli G: One hour bleaching for melanin. Stain Technol 63:325-326, 1988
13. Holmes KL, Morse HC: Murine hematopoietic cell surface antigen expression. Immunol Today 9:344-350, 1988
14. Imokawa G, Mishima Y: Loss of melanogenic properties in tyrosinases induced by glycosylation inhibitors within malignant melanoma cells. Cancer Res 42:1994-2004, 1982
15. Iwamoto T, Takahashi M, Ito M, Hamatani K, Ohbayashi M, Wajjwalku W, Isobe K-I, Nakashima I: Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J 10:3167-3175, 1991
16. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 222:680-685, 1970
17. Laskin JD, Piccinini L: Tyrosinase Isozyme heterogeneity in differentiating B16/C3 melanoma. J Biol Chem 261:16626-16635, 1986
18. Levene A: Disseminated dermal melanocytosis terminating in melanoma. A human condition resembling equine melanotic disease. Br J Dermatol 101:197-205, 1979
19. Levine A: On the histological diagnosis and prognosis of malignant melanoma. J Clin Pathol 33:101-124, 1980
20. Masson P: Pigment cells in man. In: Meiner RW (ed.). The Biology of Melanomas (Special Publication). Vol. 4. The New York Academy of Sciences, 1984, pp 15-51
21. Miettinen M, Lehto V-P, Virtanen I: Presence of fibroblast-type intermediate filaments (vimentin) and absence of neurofilaments in pigmented nevi and malignant melanomas. J Cutan Pathol 10:188-192, 1983
22. Mishima Y, Ichihasi M, Hayashibe K, Ueda M, Hatta S, Munasaka Y, Imokawa G: Control of melanogenesis and melanoma oncogenesis. In: Bagnara JT (ed.): Advances in Pigment Cell Research. Alan R. Liss, Inc., New York, pp 127-141, 1988
23. Mishima Y, Nakanishi T: Acral lentiginous melanoma and its precursor - heterogeneity of palmo-plantar melanomas. Pathology 17:258-265, 1985
24. Naruns PL, Nizze JA, Cochran AJ, Lee MB, Morton DL: Recurrence potential of thin primary melanomas. Cancer 57:545-548, 1986
25. Ohkura T, Yamashita K, Mishima Y, Kohara A: Purification of hamster melanoma tyrosinases and structural studies of their asparagine-linked sugar chains. Arch Biochem Biophys 235:63-77, 1984
26. Romerdahl C, Stephens C, Bucana C, Kripke M: The role of ultraviolet radiation in the induction of melanocytic skin tumors in inbred mice. Cancer Commun 1:209-216, 1989
27. Rosai J: Skin. In: Stamathis G (ed.). Ackerman's Surgical Pathology. 17th Ed., Vol. 1, The C.V. Mosby Company, Washington, DC, pp 53-172, 1989
28. Shokry M, Lofti MM: Malignant perianal melanoma in a horse. Mod Vet Pract 65:226, 1984
29. Sndergaard K: Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases. Acta Pathol Microbiol Immunol Scand [A] 93:49-55, 1985
30. Taniguchi M, Iwamoto T, Nakashima I, Nakayama A, Ohbayashi M, Matsuyama M, Takahashi M: Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene. Oncogene 7:1491-1496, 1992
31. Woods JE, Soule EH, Crega ET: Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg 198:63-64, 1983
32. Yurkow EJ, Laskin JD: Purification of tyrosinase to homogeneity based on its resistance to sodium dodecyl sulfate-proteinase K digestion. Arch Biochem Biophys 275:122-129, 1989